Seres Therapeutics Inc (MCRB)
1.14
+0.03
(+2.70%)
USD |
NASDAQ |
May 03, 14:23
Seres Therapeutics Net Income (Quarterly): -41.25M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -41.25M |
September 30, 2023 | -47.85M |
June 30, 2023 | 46.55M |
March 31, 2023 | -71.17M |
December 31, 2022 | -68.80M |
September 30, 2022 | -60.00M |
June 30, 2022 | -64.74M |
March 31, 2022 | -56.62M |
December 31, 2021 | -50.00M |
September 30, 2021 | 68.22M |
June 30, 2021 | -48.33M |
March 31, 2021 | -35.46M |
December 31, 2020 | -18.25M |
September 30, 2020 | -30.28M |
June 30, 2020 | -20.71M |
March 31, 2020 | -19.88M |
December 31, 2019 | -18.78M |
September 30, 2019 | -16.41M |
June 30, 2019 | -10.76M |
March 31, 2019 | -24.33M |
Date | Value |
---|---|
December 31, 2018 | -21.29M |
September 30, 2018 | -21.95M |
June 30, 2018 | -27.79M |
March 31, 2018 | -27.92M |
December 31, 2017 | -28.95M |
September 30, 2017 | -6.935M |
June 30, 2017 | -28.02M |
March 31, 2017 | -25.47M |
December 31, 2016 | -25.28M |
September 30, 2016 | -18.69M |
June 30, 2016 | -27.91M |
March 31, 2016 | -19.70M |
December 31, 2015 | -19.63M |
September 30, 2015 | -14.62M |
June 30, 2015 | -12.56M |
March 31, 2015 | -7.971M |
December 31, 2014 | -8.182M |
September 30, 2014 | -4.161M |
June 30, 2014 | -2.677M |
March 31, 2014 | -1.689M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-71.17M
Minimum
Mar 2023
68.22M
Maximum
Sep 2021
-29.71M
Average
-35.46M
Median
Mar 2021
Net Income (Quarterly) Benchmarks
Integra Lifesciences Holdings Corp | 19.83M |
Nuwellis Inc | -5.509M |
Axogen Inc | -3.893M |
Axsome Therapeutics Inc | -98.65M |
908 Devices Inc | -7.429M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 0.064M |
Total Expenses (Quarterly) | 39.59M |
EPS Diluted (Quarterly) | -0.32 |
Enterprise Value | 141.20M |
Profit Margin (Quarterly) | -64.45K% |
Earnings Yield | -78.95% |
Normalized Earnings Yield | -78.95 |